Skip to main content
Article
A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia
Circulation-cardiovascular Interventions (2012)
  • Douglas W. Losordo, Baxter International
  • Douglas W. Losordo, Northwestern University
  • Melina R. Kibbe, Northwestern University
  • Farrell Mendelsohn, Center for Therapeutic Angiogenesis
  • William Marston, University of North Carolina at Chapel Hill
  • Vickie R. Driver, Boston University
  • Melhem Sharafuddin, University of Iowa
  • Victoria Teodorescu, Icahn School of Medicine at Mount Sinai
  • Bret N. Wiechmann, Vascular and Interventional Physicians
  • Charles Thompson, Orlando Regional Medical Center
  • Larry Kraiss, University of Utah
  • Teresa Carman, Case Western Reserve University
  • Suhail Dohad, Cedars-Sinai Medical Center
  • Paul Huang, Swedish Medical Center
  • Candice E. Junge, Baxter International
  • Kenneth Story, Baxter International
  • Tara Weistroffer, Northwestern University
  • Tina M. Thorne, Northwestern University
  • Meredith Millay, Northwestern University
  • John Paul Runyon, Christ Hospital
  • Robert Schainfeld, Harvard University
Publication Date
December 1, 2012
DOI
10.1161/CIRCINTERVENTIONS.112.968321
Citation Information
Douglas W. Losordo, Douglas W. Losordo, Melina R. Kibbe, Farrell Mendelsohn, et al.. "A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia" Circulation-cardiovascular Interventions Vol. 5 Iss. 6 (2012) p. 821 - 830
Available at: http://works.bepress.com/bret-wiechmann/1/